Teresa Helsten
Professor of Medicine · University of California (San Diego) Medical Center
Credentials: · · · ·
History
- 2001–2004
Hematology and Medical Oncology
- 1998–2001
Internal Medicine
Research
The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing
Clinical Cancer Research · 2016 · First of 6 authors · Corresponding · 672 citations
JAMA Oncology · 2020 · 610 citations
Adaptive Randomization of Neratinib in Early Breast Cancer
New England Journal of Medicine · 2016 · 292 citations
- RS
13 papers
9 papers
- BP
8 papers
7 papers
7 papers
7 papers
7 papers
7 papers
Clinical trials
- 2018–2021
Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
Principal investigator · Withdrawn · Phase 2
Teresa Helsten, MD
- 2017–2022
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations
Principal investigator · Withdrawn · Phase 2
Teresa Helsten, MD